Keywords: Watson Pharma, Columbia Labs, Crinone, Pre-term birth, NDA

Columbia Labs hands over NDA to Watson

Article | 13 February 2012

Print This

Columbia Laboratories (Nasdaq: CBRX) has transferred the New Drug Application for progesterone vaginal gel 8% for use in the reduction of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in